Sheehan J E, Pitot H C, Kasper C B
McArdle Laboratory for Cancer Research, University of Wisconsin, Madison 53706.
J Biol Chem. 1991 Mar 15;266(8):5122-7.
Intraperitoneal administration of lead acetate to male Sprague-Dawley rats resulted in the tissue-specific transcriptional activation of the microsomal epoxide hydrolase gene in kidney. This response was followed by a 15-fold increase in the level of kidney epoxide hydrolase mRNA, while no change in mRNA level was noted in liver. Treated animals also showed no increase in mRNA levels for NADPH-cytochrome P-450 oxidoreductase, cytochrome P-450b/e, cytochrome P-450PCN (where PCN is pregnenolone 16 alpha-carbonitrile), or serum albumin in either kidney or liver. Immunoquantitation of the enzyme revealed a 16-fold increase in kidney upon treatment with lead acetate, but significant changes in epoxide hydrolase levels were not noted in liver, heart, spleen, lung, small intestine, or testis. The enzymatic activity for liver and kidney paralleled the immunochemical results; however, the activity increase in kidney was only one-third of the increase noted for total enzyme protein. Immunohistochemical analysis of epoxide hydrolase protein in sections of rat kidney demonstrated that in lead acetate-treated animals there was a marked increase in staining of the cytoplasm of the proximal tubular cells in the outer cortex as compared with kidneys from control animals. In contrast, considerable protein was also localized to collecting ducts, but no change was evident in the content of the epoxide hydrolase gene product in these structures in control and lead acetate-treated animals. Immunohistochemical differences were not noted between livers from control and lead-treated animals. Furthermore, the staining patterns for NADPH-cytochrome P-450 oxidoreductase were the same for control and treated animals in both kidney and liver. Quantitative measurements of lead uptake by various rat tissues showed liver, spleen, and small intestine reaching a maximum of approximately 12,000 ng of lead/g of dry tissue at 8, 8, and 16 h, respectively, while kidney, lung, and testis peaked (approximately 3,000 ng of lead/g of dry tissue) at 16, 16, and 12 h, respectively.
给雄性斯普拉格 - 道利大鼠腹腔注射醋酸铅,导致肾脏中微粒体环氧化物水解酶基因出现组织特异性转录激活。此反应之后,肾脏环氧化物水解酶mRNA水平增加了15倍,而肝脏中的mRNA水平未出现变化。经处理的动物肾脏和肝脏中,NADPH - 细胞色素P - 450氧化还原酶、细胞色素P - 450b/e、细胞色素P - 450PCN(PCN即孕烯醇酮16α - 腈)或血清白蛋白的mRNA水平也未增加。对该酶进行免疫定量分析显示,用醋酸铅处理后肾脏中的酶增加了16倍,但在肝脏、心脏、脾脏、肺、小肠或睾丸中未观察到环氧化物水解酶水平有显著变化。肝脏和肾脏的酶活性与免疫化学结果一致;然而,肾脏中酶活性的增加仅为总酶蛋白增加量的三分之一。对大鼠肾脏切片中环氧化物水解酶蛋白进行免疫组织化学分析表明,与对照动物的肾脏相比,经醋酸铅处理的动物外皮质近端肾小管细胞的细胞质染色明显增加。相比之下,集合管中也有相当数量的蛋白,但在对照动物和经醋酸铅处理的动物中,这些结构中环氧化物水解酶基因产物的含量没有明显变化。对照动物和经铅处理动物的肝脏之间未观察到免疫组织化学差异。此外,对照动物和经处理动物肾脏和肝脏中NADPH - 细胞色素P - 450氧化还原酶的染色模式相同。对各种大鼠组织中铅摄取的定量测量显示,肝脏、脾脏和小肠分别在8、8和16小时达到最大铅摄取量,约为12,000 ng铅/克干组织,而肾脏、肺和睾丸分别在16、16和12小时达到峰值(约3,000 ng铅/克干组织)。